Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009

Emerging Infectious Diseases

Volumn 18, Issue 4, 2012, Pages 598-607

  Johnson, James R ^a,b   Nicolas Chanoine, Marie Hélène ^c   Deb Roy, Chitrita ^d   Castanheira, Mariana ^e   Robicsek, Ari ^f   Hansen, Glen ^g   Weissman, Scott ^h   Urban, Carl ^i,j   Platell, Joanne ^k   Trott, Darren ^l   Zhanel, George ^m   Clabots, Connie ^a   Johnston, Brian D ^a,b   Kuskowski, Michael A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c BEAUJON HOSPITAL   (France)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

^e JMI LABORATORIES   (United States)

^f NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^g HENNEPIN COUNTY MEDICAL CENTER   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ NEW YORK HOSPITAL QUEENS   (United States)

^j NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF QUEENSLAND   (Australia)

^l UNIVERSITY OF ADELAIDE   (Australia)

^m UNIVERSITY OF MANITOBA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; DISK DIFFUSION; ESCHERICHIA COLI; GEOGRAPHIC DISTRIBUTION; GEOGRAPHIC ORIGIN; MICROBIAL DIVERSITY; MULTILOCUS SEQUENCE TYPING; MULTIVARIATE ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; HUMANS; MOLECULAR TYPING; MULTIVARIATE ANALYSIS; PHYLOGENY; PHYLOGEOGRAPHY;

EID: 84863376124     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1804.111627     Document Type: Article

References (30)

1. Peirano G, Pitout JDD. Molecular epidemiology of Escherichia coli producing CTX-M ß-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents. 2010;35:316-21. http://dx.doi.org/10.1016/j.ijantimicag.2009.11.003
2. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b- ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother. 2011;66:1-14. http://dx.doi.org/10.1093/jac/dkq415
3. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 2008;61:273-81. http://dx.doi.org/10.1093/jac/dkm464
4. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, Branger C, et al. The CTX-M-15producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother. 2008;61:1024-8. http://dx.doi.org/10.1093/jac/dkn084
5. Coque TM, Novais Â, Carattoli A, Poirel L, Pitout J, Peixe L, et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum ß-lactamase CTX-M-15. Emerg Infect Dis. 2008;14:195-200. http://dx.doi.org/10.3201/eid1402.070350
6. Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, Upton M. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from northwest England. J Antimicrob Chemother. 2012;67:346-56. http://dx.doi.org/10.1093/jac/dkr451
7. Totsika M, Beatson SA, Sarkar S, Phan MD, Petty NK, Bachmann N, et al. Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS ONE. 2011;6:e26578. http://dx.doi.org/10.1371/journal.pone.0026578
8. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States (2007). Clin Infect Dis. 2010;51:286-94. http://dx.doi.org/10.1086/653932
9. Johnson JR, Anderson JT, Clabots C, Johnston B, Cooperstock M. Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection. Pediatr Infect Dis J. 2010;29:473-5. http://dx.doi.org/10.1097/INF.0b013e3181c89bd7
10. Ender PT, Gajanana D, Johnston B, Clabots C, Tamarkin FJ, Johnson JR. Transmission of extended-spectrum beta-lactamase-producing Escherichia coli (sequence type ST131) between a father and daughter resulting in septic shock and emphysematous pyelonephritis. J Clin Microbiol. 2009;47:3780-2. http://dx.doi.org/10.1128/JCM.01361-09
11. Owens RC, Johnson JR, Stogstill P, Yarmus L, Lolans K, Quinn J. Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death. J Clin Microbiol. 2011;49:3406-8. http://dx.doi.org/10.1128/JCM.00993-11
12. Johnson JR, Miller S, Johnston B, Clabots C. DebRoy C. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and cats within a household. J Clin Microbiol. 2009;47:3721-5. http://dx.doi.org/10.1128/JCM.01581-09
13. Platell JL, Johnson JR, Cobbold RN, Trott DJ. Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods. Vet Microbiol. 2011;153:99-108. http://dx.doi.org/10.1016/j.vetmic.2011.05.007
14. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Pendyala S, DebRoy C, et al. Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients. Antimicrob Agents Chemother. 2010;54:546-50. http://dx.doi.org/10.1128/AAC.01089-09
15. Vigil KJ, Johnson JR, Johnston BD, Kontoyiannis DP, Mulanovich VE, Raad II, et al. Escherichia coli pyomyositis: an emerging entity among patients with hematologic malignancies. Clin Infect Dis. 2010;50:374-80. http://dx.doi.org/10.1086/649866
16. Urban C, Mariano N, Bradford PA, Tuckman M, Segal-Maurer S, Wehbeh W, et al. Identification of CTX-M ß-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities. Diagn Microbiol Infect Dis. 2010;66:402-6. http://dx.doi.org/10.1016/j.diagmicrobio.2009.11.012
17. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002-2004. Antimicrob Agents Chemother. 2009;53:2733-9. http://dx.doi.org/10.1128/AAC.00297-09
18. Sidjabat HE, Paterson DL, Adams-Haduch JM, Ewan L, Pasculle AW, Muto CA, et al. Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob Agents Chemother. 2009;53:4733-9. http://dx.doi.org/10.1128/AAC.00533-09
19. Lewis JS II, Herrera M, Wickes B, Patterson JE, Jorgensen JH. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a US health care system. Antimicrob Agents Chemother. 2007;51:4015-21. http://dx.doi.org/10.1128/AAC.00576-07
20. Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis. 2006;3:59-67. http://dx.doi.org/10.1089/fpd.2006.3.59
21. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-9.
22. Clinical Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests; approved standard-tenth edition. M02-A10. Wayne (PA): The Institute; 2009.
23. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. M100-S19. Wayne (PA): The Institute; 2009.
24. Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, et al. Molecular epidemiology of Escherichia coli producing extended-spectrum ß-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 2009;63:1135-41. http://dx.doi.org/10.1093/jac/dkp122
25. Manges AR, Tabor H, Tellis P, Vincent C, Tellier P-P. Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg Infect Dis. 2008;14:1575-83. http://dx.doi.org/10.3201/eid1410.080102
26. Dhanji H, Murphy NM, Doumith M, Durmus S, Lee SS, Hope R, et al. Cephalosporin resistance mechanisms in Escherichia coli isolated from raw chicken imported into the UK. J Antimicrob Chemother. 2010;65:2534-7. http://dx.doi.org/10.1093/jac/dkq376
27. Mora A, Herrera A, Mamani R, López C, Alonso MP, Blanco JE, et al. Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9producing strains, and comparison with clinical human isolates. Appl Environ Microbiol. 2010;76:6991-7. http://dx.doi.org/10.1128/AEM.01112-10
28. Vincent C, Boerlin P, Daignault D, Dozois CM, Dutil L, Galanakis C, et al. Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis. 2010;16:88-95. http://dx.doi.org/10.3201/eid1601.091118
29. Platell JL, Cobbold RN, Johnson JR, Heisig A, Heisig P, Clabots C, et al. Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob Agents Chemother. 2011;55:3782-7. http://dx.doi.org/10.1128/AAC.00306-11
30. Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas- Chanoine MH. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol. 2008;46:3900-5. http://dx.doi.org/10.1128/JCM.00734-08